Half-life
Very short; minutes
Evidence Level
Preliminary
Mechanism of Action
Modulates multiple neurotransmitter systems. Decreases ACTH and cortisol. May influence sleep EEG patterns, particularly delta wave (slow-wave sleep) enhancement.
Published Research Ranges & Study Context
Studies have administered: 0.5–30 nmol/kg in human studies
Important Research Framing
These are ranges reported in published scientific studies. They are provided for educational context only and do not constitute dosing recommendations. Individual study parameters vary by design, population, and research objectives. This information is not medical advice.
Primary Research Findings
Studies show improvements in sleep quality metrics and delta wave activity. Stress and pain studies show modest benefits. Adaptogenic-like effects on HPA axis documented.
Preliminary
Primarily preclinical + case reports
Side Effects Observed in Research
Generally well-tolerated in research doses; occasional fatigue or mild disorientation reported
Available Configurations (SKU Reference)
DS5
DS10
Compounds Studied in Combination
These compounds have been examined together in research literature. Combination use is not endorsed or recommended — this information is provided for research context only.
Want a Complete Research Monograph?
Our AI can generate a 2,000+ word deep-dive on DSIP — including full clinical trial summaries, pharmacokinetics, and research frontiers.
Generate Deep Dive in Research Chat
Research Education Only: This compound profile is for educational purposes only. All information is sourced from published scientific literature. This is not medical advice. Not for human consumption. Consult qualified medical professionals for any health decisions. Regulatory status varies by jurisdiction.